WO/2001/002369 is referenced by 3 patents.

Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Application Number
Publication Number
Application Date
June 30, 2000
Publication Date
January 11, 2001
Collins Michael Raymond
Wallace Michael Brennan
Varney Michael David
Thomas Christine
Teng Min
Tempczyk Russell Anna Maria
Reich Siegfried Heinz
Palmer Cynthia Louise
Luu Hiep The
Johnson Theodore Otto Jr
Johnson Michael David
Hua Ye
Cripps Stephan James
Braganza John F
Borchardt Allen J
Bender Steven Lee
Kania Robert Steven
Agouron Pharmaceuticals
C07D 471/04
C07D 417/14
C07D 417/12
C07D 413/12
C07D 409/14
C07D 409/12
C07D 409/06
C07D 405/14
C07D 405/06
C07D 403/14
C07D 403/12
C07D 403/04
C07D 401/14
C07D 401/12
C07D 401/06
C07D 401/04
C07D 231/56
C07D 209/18
View Original Source